
Real-World Low-Risk TAVR Patients Face Higher Mortality Risk Than Clinical Trial Participants
A recent analysis published in Circulation revealed that low-risk patients undergoing transcatheter aortic valve replacement (TAVR) in real-world settings experience a higher risk of mortality